You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

11 Results
Guidelines and Advice
Status: Current
ID: PET 17
Jan 2017
Guidelines and Advice
Status: Current
ID: PET 18
May 2017
Drug
Other Name(s): Neulasta®, Lapelga®, Fulphila™; Ziextenzo®; Nyvepria™, Niopeg®, Pexegra™
Updated
Aug 2025
Drug
Other Name(s): Caelyx®
Updated
Aug 2025
Regimen
Cancer Type:
Hematologic, 
Leukemia - Chronic Lymphocytic (CLL)
Intent: Palliative
Oct 2017
Guidelines and Advice
Nov 2017
Guidelines and Advice